NuvaHealth Review
NuvaHealth is no longer available as we reviewed it, so this page is kept for reference.
NuvaHealth: Website no longer loads and is not taking patients. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →NuvaHealth was a compounded GLP-1 telehealth platform with a Newark, Delaware address that sold compounded semaglutide and tirzepatide, including tablet forms, at low first-month prices. Its website no longer loads: on October 30, 2026 the address returned a hosting error instead of a page, so there is no way to sign up, refill or check prices.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to NuvaHealth
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
NuvaHealth at a glance
- Type
- GLP-1 telehealth provider
- FDA status
- No FDA warning letter on record
How we scored NuvaHealth
Each dimension is scored algorithmically from NuvaHealth’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.2/10NuvaHealth no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
6.6/10NuvaHealth's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence, so weigh the clinical support carefully.
User Experience15%
8.0/10Online intake and platform experience; 2 platform features disclosed.
Trust & Safety15%
8.1/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.2/10NuvaHealth's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
7.0/10NuvaHealth provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this NuvaHealth review
Last checked August 2026- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What we like
- Review page kept live so former patients get a straight answer
Watch-outs
- Website no longer loads, so there is no way to sign up or reorder
- No closure notice or new contact route has been published for former patients
NuvaHealth's website no longer loads and it is not taking patients
If you came here looking for NuvaHealth's compounded semaglutide and tirzepatide program, there is nothing left to sign up for. When we checked on October 30, 2026, its website returned a hosting error instead of a page, so there are no prices, no intake and no way to reorder.
When it was running, NuvaHealth listed a Newark, Delaware address and sold compounded GLP-1 injections and tablets at low first-month prices, with the ongoing price shown only at checkout. It never named its pharmacy partners or its legal entity on the home page. The company has published no closure notice and no new address, so we treat it as closed until it comes back with a working site.
What to do if you were a patient
Talk with a prescriber before your current supply runs out. A GLP-1 dose should be continued or adjusted on clinical advice, not interrupted because a provider went offline, and restarting at a high dose after a gap can be unsafe. If your medication label names a pharmacy, keep that information handy, because the dispensing pharmacy is a separate business from the platform that arranged your visits.
If you were taking tablets, keep in mind that there is no FDA-approved oral tirzepatide, so a new provider may suggest a different form or medication. Bring your current dose and how long you have been on it to that first visit.
Where to look instead
The alternatives listed on this page are all currently operating and carry current prices. You can also start from our semaglutide provider rankings and compare what each provider includes as well as what it charges, using the factors in our scoring methodology.
Bottom line
NuvaHealth is no longer reachable online and is not taking patients. We keep this page up so people searching for it get a clear answer rather than a dead link. It is excluded from our rankings and carries no outbound link.
The Bottom Line
NuvaHealth is no longer available as we reviewed it, so this page is kept for reference.
NuvaHealth might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this NuvaHealth review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.